Susanne Bremer‐Hoffmann

1.1k total citations
21 papers, 732 citations indexed

About

Susanne Bremer‐Hoffmann is a scholar working on Materials Chemistry, Molecular Biology and Immunology. According to data from OpenAlex, Susanne Bremer‐Hoffmann has authored 21 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Materials Chemistry, 6 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Susanne Bremer‐Hoffmann's work include Nanoparticles: synthesis and applications (8 papers), Biosimilars and Bioanalytical Methods (5 papers) and 3D Printing in Biomedical Research (4 papers). Susanne Bremer‐Hoffmann is often cited by papers focused on Nanoparticles: synthesis and applications (8 papers), Biosimilars and Bioanalytical Methods (5 papers) and 3D Printing in Biomedical Research (4 papers). Susanne Bremer‐Hoffmann collaborates with scholars based in Italy, Belgium and Germany. Susanne Bremer‐Hoffmann's co-authors include Blanka Halamoda‐Kenzaoui, Alessia Bogni, Francesca Pistollato, Sven Even Borgos, Uwe Holzwarth, Fanny Caputo, Gert Roebben, Adriele Prina‐Mello, Dimitra Zagoura and Ciarán Manus Maguire and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Journal of Controlled Release.

In The Last Decade

Susanne Bremer‐Hoffmann

21 papers receiving 719 citations

Peers

Countries citing papers authored by Susanne Bremer‐Hoffmann

Since Specialization

Citations

This map shows the geographic impact of Susanne Bremer‐Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne Bremer‐Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne Bremer‐Hoffmann more than expected).

Fields of papers citing papers by Susanne Bremer‐Hoffmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanne Bremer‐Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne Bremer‐Hoffmann. The network helps show where Susanne Bremer‐Hoffmann may publish in the future.

Co-authorship network of co-authors of Susanne Bremer‐Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Susanne Bremer‐Hoffmann. A scholar is included among the top collaborators of Susanne Bremer‐Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanne Bremer‐Hoffmann. Susanne Bremer‐Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proposal for a qualification system for New Approach Methodologies (NAMs) in the food and feed sector: example of implementation for nanomaterial risk assessment 2024 ·EFSA Supporting Publications ·Andrea Haase, José G. Barroso, Alessia Bogni, Susanne Bremer‐Hoffmann, Valérie Fessard, Arno C. Gutleb, Jan Mast, (unknown), Birgit Mertens, Agnes G. Oomen, Vera Ritz, Tommaso Serchi, Katherina Siewert, D. Stanco, (unknown), Eveline Verleysen, Olimpia Vincentini, Meike van der Zande, Francesco Cubadda	9
2	An Adverse Outcome Pathway for food nanomaterial-induced intestinal barrier disruption 2024 ·SHILAP Revista de lepidopterología ·D. Stanco, (unknown), Alessia Bogni, Susanne Bremer‐Hoffmann, Laure‐Alix Clerbaux	1
3	Inter-Individual Variations: A Challenge for the Standardisation of Complement Activation Assays 2023 ·International Journal of Nanomedicine ·(unknown), Ana Ruiz, Cloé Desmet, Ivana Bianchi, Otmar Geiss, Pascal Colpo, Susanne Bremer‐Hoffmann	4
4	Future perspectives for advancing regulatory science of nanotechnology-enabled health products 2022 ·Drug Delivery and Translational Research ·Blanka Halamoda‐Kenzaoui, Robert E. Geertsma, (unknown), Adriele Prina‐Mello, (unknown), Matthias Roesslein, Adriënne J.A.M. Sips, (unknown), Kathleen Spring, Susanne Bremer‐Hoffmann	14
5	Tiered testing of micro- and nanoplastics using intestinal in vitro models to support hazard assessments 2021 ·Environment International ·Gerrit Bredeck, Blanka Halamoda‐Kenzaoui, Alessia Bogni, (unknown), Susanne Bremer‐Hoffmann	30
6	Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation 2021 ·Journal of Controlled Release ·Blanka Halamoda‐Kenzaoui, Rob J. Vandebriel, (unknown), Marco Siccardi, Christopher David, Neill J. Liptrott, Matteo Santin, Sven Even Borgos, Susanne Bremer‐Hoffmann, Fanny Caputo	54
7	Toxic effects of nanomaterials for health applications: How automation can support a systematic review of the literature? 2021 ·Journal of Applied Toxicology ·Blanka Halamoda‐Kenzaoui, (unknown), (unknown), (unknown), Susanne Bremer‐Hoffmann	14
8	Launching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health products 2020 ·SHILAP Revista de lepidopterología ·Blanka Halamoda‐Kenzaoui, (unknown), Merel van Elk, (unknown), Robert E. Geertsma, (unknown), Andrew Owen, (unknown), Matthias Roesslein, Susanne Bremer‐Hoffmann	14
9	Nanomedicines - Tiny particles and big challenges 2019 ·Advanced Drug Delivery Reviews ·Margareth Marques, Qiuyi Choo, Mukul Ashtikar, (unknown), Susanne Bremer‐Hoffmann, Matthias G. Wacker	80
10	Identification of regulatory needs for nanomedicines 2018 ·Joint Research Centre (European Commission) ·Susanne Bremer‐Hoffmann, Blanka Halamoda‐Kenzaoui, Sven Even Borgos	54
11	Main trends of immune effects triggered by nanomedicines in preclinical studies 2018 ·International Journal of Nanomedicine ·Blanka Halamoda‐Kenzaoui, Susanne Bremer‐Hoffmann	72
12	Are Existing Standard Methods Suitable for the Evaluation of Nanomedicines: Some Case Studies 2018 ·Nanomedicine ·Sabrina Gioria, Fanny Caputo, Patricia Urbán, Ciarán Manus Maguire, Susanne Bremer‐Hoffmann, Adriele Prina‐Mello, Luigi Calzolai, Dóra Méhn	105
13	Mapping of the available standards against the regulatory needs for nanomedicines 2018 ·Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology ·Blanka Halamoda‐Kenzaoui, Uwe Holzwarth, Gert Roebben, Alessia Bogni, Susanne Bremer‐Hoffmann	96
14	Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells 2016 ·Neurochemistry International ·Dimitra Zagoura, (unknown), Francesca Pistollato, Susanne Bremer‐Hoffmann, Anna Bal‐Price	56
15	Nanomedicines in the European translational process 2015 ·Joint Research Centre (European Commission) ·Susanne Bremer‐Hoffmann, Valeria Amenta, François Rossi	7
16	Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles 2015 ·Targeted Oncology ·Francesca Pistollato, Susanne Bremer‐Hoffmann, Giuseppe Basso, Sandra Cano, Iñaki Elío, Manuel Masias Vergara, Francesca Giampieri, Maurizio Battino	35
17	Development of a pluripotent stem cell derived neuronal model to identify chemically induced pathway perturbations in relation to neurotoxicity: Effects of CREB pathway inhibition 2014 ·Toxicology and Applied Pharmacology ·Francesca Pistollato, Jochem Louisse, Bibiana Scelfo, Milena Mennecozzi, Benedetta Accordi, Giuseppe Basso, John Antonydas Gaspar, Dimitra Zagoura, (unknown), Taina Palosaari, Agapios Sachinidis, Susanne Bremer‐Hoffmann	30
18	Standardization of pluripotent stem cell cultures for toxicity testing 2012 ·Expert Opinion on Drug Metabolism & Toxicology ·Francesca Pistollato, Susanne Bremer‐Hoffmann, Lyn Healy, (unknown), Glyn Stacey	31
19	MicroRNA Profiling as a Tool for Pathway Analysis in a Human In Vitro Model for Neural Development 2012 ·Current Medicinal Chemistry ·Silvia Nerini‐Molteni, Milena Mennecozzi, Marco Fabbri, Maria Grazia Sacco, Kinga Vojnits, Adriana Compagnoni, Laura Gribaldo, Susanne Bremer‐Hoffmann	14
20	A Transcriptomics Study to Elucidate the Toxicological Mechanism of Methylmercury Chloride in a Human Stem Cell Based In Vitro Test 2012 ·Current Medicinal Chemistry ·Kinga Vojnits, (unknown), John Antonydas Gaspar, Kesavan Meganathan, Smita Jagtap, J. Hescheler, Agapios Sachinidis, Susanne Bremer‐Hoffmann	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact